Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US

At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human vaccines 2011-01, Vol.7 (1), p.12-18
Hauptverfasser: Shen, Angela K, Sobzcyk, Elizabeth, Buchanan, Anna, Wu, Lauren, Duggan-Goldstein, Sarah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue 1
container_start_page 12
container_title Human vaccines
container_volume 7
creator Shen, Angela K
Sobzcyk, Elizabeth
Buchanan, Anna
Wu, Lauren
Duggan-Goldstein, Sarah
description At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.
doi_str_mv 10.4161/hv.7.1.13949
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_865185921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>865185921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0Eggq6MSNvLKTYSewkbFXFo1IFQylisxz7mholTrGTSvDrSR905S6-5-jTudZB6JKSUUo5vV2uR9mIjmhSpMURGsSUpxFj6fvxYafsDA1D-CT9ZCROOT9FZzGlWZ4U2QDJOajGafwsW9s4WeFpXXfO_mwlnjTuw0MIOCaU3OGx1htl3QdeS6WsA2ysk05tHNN43C57p2s7D9i6rVrML9CJkVWA4f49R4uH-9fJUzR7eZxOxrNIxSwvopwkBlhZJlxKkieJNDIlsih13BsUQHFjJCdFrEASzRno0qispKXJtGEJS87R9S535ZuvDkIrahsUVJV00HRB5JzRnBUx7cmbHal8E4IHI1be1tJ_C0rEplaxXItMULGttcev9sFdWYM-wH8l9kC0A_pTGkJpm6AsOAUHdL4E9_S2iVxp0_P8H37fbhDSt1ZVsP_JLwI5mP4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>865185921</pqid></control><display><type>article</type><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</creator><creatorcontrib>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</creatorcontrib><description>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</description><identifier>ISSN: 2164-5515</identifier><identifier>ISSN: 1554-8600</identifier><identifier>EISSN: 2164-554X</identifier><identifier>EISSN: 1554-8619</identifier><identifier>DOI: 10.4161/hv.7.1.13949</identifier><identifier>PMID: 21178397</identifier><language>eng</language><publisher>United States</publisher><subject>Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; Communicable Diseases - epidemiology ; Cycle ; Health Policy ; Humans ; Landes ; Organogenesis ; Proteins ; Public-Private Sector Partnerships - trends ; United States - epidemiology ; Vaccination - economics ; Vaccination - trends ; Vaccines - economics ; Vaccines - immunology</subject><ispartof>Human vaccines, 2011-01, Vol.7 (1), p.12-18</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21178397$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Angela K</creatorcontrib><creatorcontrib>Sobzcyk, Elizabeth</creatorcontrib><creatorcontrib>Buchanan, Anna</creatorcontrib><creatorcontrib>Wu, Lauren</creatorcontrib><creatorcontrib>Duggan-Goldstein, Sarah</creatorcontrib><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><title>Human vaccines</title><addtitle>Hum Vaccin</addtitle><description>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</description><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Communicable Diseases - epidemiology</subject><subject>Cycle</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Landes</subject><subject>Organogenesis</subject><subject>Proteins</subject><subject>Public-Private Sector Partnerships - trends</subject><subject>United States - epidemiology</subject><subject>Vaccination - economics</subject><subject>Vaccination - trends</subject><subject>Vaccines - economics</subject><subject>Vaccines - immunology</subject><issn>2164-5515</issn><issn>1554-8600</issn><issn>2164-554X</issn><issn>1554-8619</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAUhS0Eggq6MSNvLKTYSewkbFXFo1IFQylisxz7mholTrGTSvDrSR905S6-5-jTudZB6JKSUUo5vV2uR9mIjmhSpMURGsSUpxFj6fvxYafsDA1D-CT9ZCROOT9FZzGlWZ4U2QDJOajGafwsW9s4WeFpXXfO_mwlnjTuw0MIOCaU3OGx1htl3QdeS6WsA2ysk05tHNN43C57p2s7D9i6rVrML9CJkVWA4f49R4uH-9fJUzR7eZxOxrNIxSwvopwkBlhZJlxKkieJNDIlsih13BsUQHFjJCdFrEASzRno0qispKXJtGEJS87R9S535ZuvDkIrahsUVJV00HRB5JzRnBUx7cmbHal8E4IHI1be1tJ_C0rEplaxXItMULGttcev9sFdWYM-wH8l9kC0A_pTGkJpm6AsOAUHdL4E9_S2iVxp0_P8H37fbhDSt1ZVsP_JLwI5mP4</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Shen, Angela K</creator><creator>Sobzcyk, Elizabeth</creator><creator>Buchanan, Anna</creator><creator>Wu, Lauren</creator><creator>Duggan-Goldstein, Sarah</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</title><author>Shen, Angela K ; Sobzcyk, Elizabeth ; Buchanan, Anna ; Wu, Lauren ; Duggan-Goldstein, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2589-803fe5bb36aa0833afa40a9bd26aa1eec6ffa6092cea0d65edbfc7b1bf7df5353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Communicable Diseases - epidemiology</topic><topic>Cycle</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Landes</topic><topic>Organogenesis</topic><topic>Proteins</topic><topic>Public-Private Sector Partnerships - trends</topic><topic>United States - epidemiology</topic><topic>Vaccination - economics</topic><topic>Vaccination - trends</topic><topic>Vaccines - economics</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Angela K</creatorcontrib><creatorcontrib>Sobzcyk, Elizabeth</creatorcontrib><creatorcontrib>Buchanan, Anna</creatorcontrib><creatorcontrib>Wu, Lauren</creatorcontrib><creatorcontrib>Duggan-Goldstein, Sarah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human vaccines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Angela K</au><au>Sobzcyk, Elizabeth</au><au>Buchanan, Anna</au><au>Wu, Lauren</au><au>Duggan-Goldstein, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US</atitle><jtitle>Human vaccines</jtitle><addtitle>Hum Vaccin</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>7</volume><issue>1</issue><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>2164-5515</issn><issn>1554-8600</issn><eissn>2164-554X</eissn><eissn>1554-8619</eissn><abstract>At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors – manufacturers, providers, public health, employers, payors, insurers, and consumers – will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.</abstract><cop>United States</cop><pmid>21178397</pmid><doi>10.4161/hv.7.1.13949</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2164-5515
ispartof Human vaccines, 2011-01, Vol.7 (1), p.12-18
issn 2164-5515
1554-8600
2164-554X
1554-8619
language eng
recordid cdi_proquest_miscellaneous_865185921
source MEDLINE; Alma/SFX Local Collection
subjects Binding
Biology
Bioscience
Calcium
Cancer
Cell
Communicable Diseases - epidemiology
Cycle
Health Policy
Humans
Landes
Organogenesis
Proteins
Public-Private Sector Partnerships - trends
United States - epidemiology
Vaccination - economics
Vaccination - trends
Vaccines - economics
Vaccines - immunology
title Second National Immunization Congress 2010: Addressing vaccine financing for the future in the US
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A31%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Second%20National%20Immunization%20Congress%202010:%20Addressing%20vaccine%20financing%20for%20the%20future%20in%20the%20US&rft.jtitle=Human%20vaccines&rft.au=Shen,%20Angela%20K&rft.date=2011-01-01&rft.volume=7&rft.issue=1&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.4161/hv.7.1.13949&rft_dat=%3Cproquest_pubme%3E865185921%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=865185921&rft_id=info:pmid/21178397&rfr_iscdi=true